Sponsor:
Jasper Therapeutics, Inc.
Code:
NCT04429191
Conditions
MYELODYSPLASTIC SYNDROME; MDS
ACUTE MYELOID LEUKEMIA; AML
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-09. This information was provided to ClinicalTrials.gov by Jasper Therapeutics, Inc. on 2021-06-11.